HRMY
Harmony Biosciences Holdings
$36.01
+$0.69 (+1.95%)Jul 27, 2026
Key metrics
The numbers that frame HRMY today
- Market cap
- $2.08B
- P/E (TTM)
- 14.3
- EV / FCF
- 4.8
- Gross margin
- 76.5%
- EV / Sales
- 1.8
- ROIC
- 48.5%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $25.52
- 52wk High
- $40.87
Growth
Revenue and earnings trend for HRMY
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HRMY
Is Harmony Biosciences Holdings a good buy?
Yes. Harmony Biosciences Holdings has excellent quality and strong momentum. Both signals support the setup. Growth looks weak, a caveat that does not overturn the setup. We think Harmony Biosciences Holdings is selling at a low price.
What is the market capitalization of HRMY?
Harmony Biosciences Holdings's market capitalization is $2.08B.
What is the P/E ratio for HRMY stock?
Harmony Biosciences Holdings's current P/E ratio is 14.3.
What is the 52-week high for HRMY stock?
The 52-week high for Harmony Biosciences Holdings is $40.87. The current close of $36.01 is 11.9% below that high.
What is the 52-week low for HRMY stock?
The 52-week low for Harmony Biosciences Holdings is $25.52. The current close of $36.01 is 41.1% above that low.
Does HRMY stock pay dividends?
Harmony Biosciences Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HRMY?
Harmony Biosciences Holdings's Debt / Equity ratio is 0.17.